Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kligman's combination with or without topical metformin for melasma
IRCT20150706023081N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metformin in melasma (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: MASI score, Satisfaction level and 2 more. Started Jan 2024; status: completed.
02
Drugs
metformin
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20150706023081N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023081N2.